A study also demonstrated that GATA2 overexpression led to increased proliferation of SW1783 glioma cells, whereas GATA2 knockdown notably inhibited the proliferation of U87 glioma cells [84]. This evidence concerns the gene GATA2 and central nervous system cancer.